Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.

Pulli B, Wojtkiewicz G, Iwamoto Y, Ali M, Zeller MW, Bure L, Wang C, Choi Y, Masia R, Guimaraes AR, Corey KE, Chen JW.

Radiology. 2017 Aug;284(2):390-400. doi: 10.1148/radiol.2017160588. Epub 2017 Mar 30.

2.

In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.

Kirschbaum K, Sonner JK, Zeller MW, Deumelandt K, Bode J, Sharma R, Kr├╝wel T, Fischer M, Hoffmann A, Costa da Silva M, Muckenthaler MU, Wick W, Tews B, Chen JW, Heiland S, Bendszus M, Platten M, Breckwoldt MO.

Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13227-13232. Epub 2016 Oct 31.

3.

Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.

Li-ChunHsieh K, Schob S, Zeller MW, Pulli B, Ali M, Wang C, Chiou TT, Tsang YM, Lee PS, Stossel TP, Chen JW.

J Neuroimmunol. 2015 Oct 15;287:36-42. doi: 10.1016/j.jneuroim.2015.08.006. Epub 2015 Aug 9.

4.

Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.

Pulli B, Ali M, Iwamoto Y, Zeller MW, Schob S, Linnoila JJ, Chen JW.

Antioxid Redox Signal. 2015 Dec 1;23(16):1255-69. doi: 10.1089/ars.2014.6108. Epub 2015 Jun 24.

Supplemental Content

Loading ...
Support Center